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The autoantibodies directed against actin and myosine have been detected in the blood 
sera of patients with dilated cardiomyopathy (DCMP) at the level that was sufficiently 
higher than in healthy donors. While comparing of the immunogeneicity of these pro­
teins we have stated that myosine from affected by DCMP myocardium have been more 
immunogenic then from normal one. In the case of actin the immunogeneicity have been 
higher for the protein from normal myocard. The investigations of actin by limited 
proteolysis may suggest that the differencies in immune properties are not connected 
with primary structure but with structures of higher levels. 
Introduction. Nowadays the presence of autoimmune processes during 
the development of various pathologies including heart diseases is obvi­
ous. At the same time the functional activity of autoAbs wasn't exami­
ned enough. The investigation of structural and functional properties of 
autoantibodies (aAbs) directed against antigens from heart and vessels, 
the establishment of their role while the origin and development of heart 
diseases is necessary not only for theoretical but for practical aims also, 
in the context of developing of novel therapeutic and diagnostic prepa­
rations [1]. 
The aim of our investigation was to study the molecular mechanisms 
of autoantibodygenesis directed against the most important tissue-speci­
fic antigens — actin and myosin, during development of dilated cardio­
myopathy (DCMP). In recent studies the aAbs directed against adenine 
nucleotide translocator (ANT) [2], the mitochondrial enzyme from myo­
cytes were detected; the aAbs directed against another mitochondrial en­
zyme, branched chain keto acid dehydrogenase (BCKD) [3] were also 
described at DCMP and myocarditis. The laboratory of Limas (USA) 
during recent years studied the structure and properties of aAbs directed 
against p-adrenoreceptor [4—8]; these aAbs were detected in 30—40 % 
of patients with DCMP. The presence of aAbs directed against myosin, 
tropomyosin, vimentin, laminin at some heart diseases such as postmyo-
cardial infarction syndrome, dilated cardiomyopathy, infectious myocar­
ditis, and doxorubicin (Adriamycin) cardiotoxicity [9]' is occasionally 
accompanied by the deposition of antibodies within the myocardium, par­
ticularly on the sarcolemma. 
The present paper is a first stage of study of aAbs, their properties 
and role at DCMP progressing, which are directed against the most 
abundant heart antigens — actin and myosin. 
The method described [10] for purifing of preparative quantities of 
antigens from human myocardium (pathomorphological material) enabled 
us to obtain the mentioned above antigens as from normal myocardium 
as from myocardium, affected by DCMP. 
The presence of aAbs in the sera of patients with DCMP was not 
unexpected because many facts suggested the presence of cellular and 
humoral immunity in the development of DCMP {4]. These data concern 
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the introduction of Igs (in the form of immune complexes) in affected 
myocardium, the abnormalities in relative proportion and function of pe­
ripheric lymphocytes, the occurrence of cytokines and existance of vari­
ous aAbs directed against surface and intracellular components of myo­
cytes. Meanwhile the correlation of mentioned processes with the clinical 
manifestation of diseases wasn't identified yet. 
Materials and methods. The sera from DCMP patients were kindly 
provided by Strazesko Institute for Cardiology. The 45 sera from pati­
ents with DCMP and 38 sera from healthy donors were examined. The 
* 
Fig 1 The immunoreactivity of sera of patients with DCMP directed against myosin 
purified from normal (light columns) and DCMP myocardium (dark columns). The im­
munoreactivity was detected as described in Materials and methods 
Fig 2 The immunoreactivity of sera of patients with DCMP directed against actin pu­
rified from normal (light columns) and DCMP myocardium (dark columns), ihe immu­
noreactivity was detected as described in Materials and methods 
diagnosis was provided according to the World Health Organization 
criteria. , 
P u r i f i c a t i o n of a c t i n a n d m у о s і n. The preparations of 
actin and myosin (90 % purity) were obtained from healthy and affected 
by DCMP myocardium as described [1]. The purity of preparations was 
controlled by the electrophoresis according Laemmly [11]. 
E L I S A. The immunoreactivity of the patients sera was detected 
by the ELISA method [13] with modifications. The antigens were immo­
bilized overnight at 4 °С in 0.1 M carbonate buffer, pH 8.0. The concen­
trations of antigens were 5 pig per ml. Tubulin, DNA from salmon sperm, 
trinitrophenol (TNP, «Sigma») and total preparation of human IgG from 
healthy donors obtained by method [12] were used as control antigens. 
The human anti-IgG conjugated with peroxidase was purchased 
from DiaGen, Moscow. The results of ELISA were calculated as descri­
bed in [14]. 
D e t e c t i o n of IgG a n d IgM in t h e s e r a of p a t i ­
e n t s . The concentrations of IgG and IgM in the sera investigated were 
determined by ELISA method [13] with standard human sera from «Bo-
ehringer» (Germany) as control. 
L i m i t e d p r o t e o l y s i s . The limited proteolysis of actin prepa­
rations from normal and affected by DCMP myocardium was provided 
as described [15] with several modifications: pH 8.0, temperature 20 °С, 
enzyme-substrate ratio 1 : 100, TPCK-treated trypsin from «Sigma» 
(USA) The proteolysis time was from 15 to 60 min. The results of hyd­
rolysis were detected by SDS-gel electrophoresis [11]. The gels were 
scanned by Ultroscan (LKB, Sweden). 
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Results and discussion. Table shows the concentrations of IgG and 
IgM in the investigated sera of patients with DCMP and healthy donors. 
It is obvious that Ig concentrations are different and don't depend on 
kind and stage of disease. 
The immunoreactivity of sera from DCMP patients against actin and 
myosin from normal and affected by DCMP myocardium. Fig. 1 shows 
the immunoreactivity of DCMP patients sera against myosin from nor­
mal and affected by DCMP myocardium. It's obvious that immunoreac­
tivity of sera against DCMP-myosin is higher then in the case of myosin 
from normal heart. In the case 
of actin it was vice versa (Fig. М^Ґт v 
2). As it was shown by us ear­
lier [10] myosin and actin pre­
parations from normal and 
Fig. 3. The densitogramm of proteo­
lytic cleavage of myosine preparations 
from normal (solid line) and DCMP 
myocardium (dotted line). The positi­
on of molecular mass markers are in­
dicated by arrows. A — position of 
undigested actin. The proteolysis was 
conducted as described in Materials 
and methods 
DCMP-myocardium possess the same Mr and isoelectric point these 
results suggest that the structure peculiarities aren't connected with the 
primary structure of the molecules. We believe that the differencies in 
the immunogeneicity are connected with certain conformational changes. 
It's well known that protein folding is sufficient for their immunological 
properties [16, 17]. The protein conformation depends on posttranslation 
modifications and intracellular media, that is especially sufficient for ac­
tin and myosin molecules, that form «molecular motor» among and with 
a help of many other proteins: besides tropomyosin and family of tropo-
nines, nowadays at least 8 proteins are known to take part in functio­
ning of this system [18]. 
We proceeded our work in the field of search of possible reasons in 
the changes of immunogeneicity of myocardial tissue-specific antigens at 
DCMP progressing on the conformational level of mentioned proteins. 
Concentrations of IgG and IgM in the sera of patients with DCMP (1—22) and sera 
of healthy donors (23—32) (the most immunoreactive sera are presented); 
33 — control serum 
Serum N 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
IgM, mg/ml 
,1.18 
3,6 
1.7 
3.02 
2.48 
1.9 
1.2 
0.9 
0.5 
0.8 
1.97 
0.95 
1.02 
0.9 
0.95 
1.3 
2.23 
IgQ. mg/ml 
26.43 
23.47 
30.35 
14.63 
14.12 
7.7 
18.77 
14.82 
14.5 
14.08 
11.2 
19.5 
13.2 
26.42 
6.7 
19.5 
25.6 
Serum N 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
IgM, mg/ml 
0.9 
0.92 
1.33 
2.29 
0.98 
1.33 
1.1 
2.1 
0.94 
2.23 
0.5 
1.26 
0.96 
2.01 
1.05 
0.58 
IgG, mg/ml 
13.5 
13.7 
14.65 
18.61 
20.48 
19,92 
22.53 
18.17 
15.17 
17.07 
15 22 
16.56 
13.89 
11.2 
23.5 
12.24 
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The first stage of these investigations was the study of the limited pro­
teolysis of actin molecule. 
The results of actin limited proteolysis are shown at Fig. 3. From 
the densitogramm it's obvious that the spectrum of the fragments obta­
ined is alike for both preparations. At the same time the intensivity of 
digestion of actin from myocardium affected by DCMP is higher then 
in the case of normal tissue that is expressed in higher concentrations 
of low molecular weight fragments (14 and 23 % for fragment with Mr 
12.000, respectively). The mentioned differencies in the intensivity of ac­
tin preparations digestion may suggest the presence of certain confor­
mational differencies in actin molecules in the preparations that leads 
to the better digestion of actin preparations from myocardium affected 
by DCMP. At the same time the absence of differencies in the spectrum 
of proteolytic fragments suggests the absence of changes in the primary 
structure of proteins. 
In the present paper we had shown the presence of aAbs directed 
against two tissue-specific myocardial proteins — actin and myosin. 
In the recent investigations the aAbs directed against ANT and 
BCKD from myocyte mitochondria as well as p-adrenoreceptor [4—8] 
was described. The aAbs directed against myosin were detected only at 
experimentally induced myocarditis in mice [19]. The investigations of 
autoantibodygenesis against actin and myosin put forward several im­
portant questions. First, myosin and actin represent the intracellular an­
tigens. The origin of aAbs against them as well as aAbs against any 
other intracellular is unclear [20]. 
It seems possible that aAbs directed against intracellular antigens 
may be induced by viral infection, for example, Coxaki CB3, that may 
induce myocarditis in mice [1, 21]. 
The overlapping peptides from myosin were synthesied and with a 
help of them the autoimmune epitope of the heavy chain of a-isoform of 
myosin had been localized. It was also shown that myocarditogenic forms 
do not possess crossreactivity with myosin [1, 9]. Kanningham had shown 
the immunological crossreactivity among several a-spiralic proteins in­
cluding myosin, tropomyosin, vimentin, M-protein from streptococcus and 
laminin, the surface protein from cardiomyocytes with a help of monoclo­
nal antibodies [1]. The peptides from Лі-protein had shown the high struc­
tural homology with myosin and laminin. 
It's likely that in humans the progression of disease is more compli­
cated then in mice. Kandolf had shown during the last stages of myocar­
ditis and DCMP the limited replication of viral RNA, and Weiss had not 
detected CB3 by PCR method [1]. So we can consider autoimmune me­
chanisms sufficient in the origin of DCMP pathogenesis. 
One of the possible explanations of the origin of autoimmune disea­
ses is that viral infection [20, 21] leads to the secretion of antigen which 
are identified by «professional» antigen-presenting dendrite cells in car­
dial matrix. Moreover, in humans the degree of cellular inflammation and 
rigidity of myocyte destruction doesn't correlate exactly with cardial dis­
function that is in order with suggestion of aAbs directed against 
myocyte antigen participation in the pathogenesis of myocarditis 
and DCMP. 
It seems reasonable to focuse our investigations on the heavy myo­
sin chain as the most immunogenic part of the molecule. It's a problem 
of special interest because in mice the immunization by myosin heavy 
chain induced the myocarditis that was similar to that caused by Coxaki 
virus CB3. At the same time it's well known that in many cases myocar­
ditis leads to the progression of severe DCMP forms and aAbs spectra 
are very similar at these pathologies. Moreover, the investigation of this 
myosin epitope is sufficient not only from the point of view of search of 
target antigen while cardiomyopathy development but also helps in un­
derstanding of the functional role of aAbs directed against tissue-speci­
fic myocardial antigens at DCMP. Even in the case of described auto-
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antigens at DCMP (as ANT or p-adrenoreceptor) the function of aAbs 
in the origin and pathogenesis of disease is unclear yet. 
It's obvious that the study of structure and properties of autoanti-
gens and their possible modifications must be conducted simultaneously. 
This may help us in the understanding of the other aspect of autoimmune 
disease development: what leads to the immunogeneicity of autoantigen 
leading to the absence of tolerance to «own» antigens? We consider im­
portant the further investigation of antigens from normal and affected 
by DCMP myocardium, and the same antigens from skeletal and smooth 
muscle by conformational methods such as spectrofluorimetry, circular 
dichroism, electronic paramagnetic resonance and so on. 
The further investigation of autoantibodygenesis against the compo­
nents of contractile apparatus of myocytes may help to obtain the new 
information about actin and myosin functioning because aAbs are often 
directed against another epitopes of the same antigen that are evolutio­
nary conserved and possess functional importance [22]. The data of our 
investigations may help not only to understand the mechanisms of DCMP 
development but other heart diseases as well. 
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ДОСЛІДЖЕННЯ АУТОАНТИТІЛ ДО ТКАНИНОСПЕЦИФІЧНИХ 
АНТИГЕНІВ МІОКАРДА ПРИ ДИЛЯТАЦІЙНІИ КАРДЮМЮПАТИ 
Р е з ю м е 
У роботі досліджено аутоантитіла проти тканиноспецифічних антигенів міокарда лю­
дини— актина і міозина. Методом твердофазного імуноферментного аналізу (ELISA) 
показано, що імунореактивність сироваток крові пацієнтів з дилятаційною кардіоміо-
патією (ДКМП) проти досліджених антигенів суттєво вища, ніж у здорових донорів. 
При порівнянні імунореактивності однакових сироваток проти антигенів, виділених 
із нормального і ураженого ДКМП міокарда, виявлено наступну закономірність: 
імунна відповідь на міозин із нормального міокарда була слабшою, ніж на той же 
білок із міокарда, ураженого ДКМП. Для актина спостерігалася зворотна залежність. 
Аналіз актина із нормального і ураженого ДКМП міокарда за допомогою методу 
обмеженого протеолізу дозволяє вважати, що з розвитком ДКМП цей білок підда­
ється субмолекулярним (скоріш за все, конформаційним) модифікаціям, які призво­
дять до змін його імунореактивності. Отримані результати обговорюються з позиції 
функціонування скорочувального апарату кардіоміоцитів. 
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